Institutional investors purchased a net $2.9 million shares of IMMU during the quarter ended June 2015, and now own 44.08% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 700.00 shares of Immunomedics Inc
LIFESCI INDEX PARTNERS LLC Sold 5.0 Thousand shares of Immunomedics Inc
SATUIT FUNDS MANAGEMENT LLC Sold 8.4 Thousand shares of Immunomedics Inc